News | March 31, 2026
Kenvue unleashes science-driven skincare offensive at American Academy of Dermatology meet
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
Allergan also presented new insights on the growing population of patients on GLP-1 agonists for weight loss who are seeking aesthetic treatments
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments
The therapy works by targeting interleukin-13, a key driver of inflammation behind eczema symptoms such as itching, skin damage, and infection
As Tracky launches integrated health solution
TERN-701, a next-generation therapy targeting chronic myeloid leukemia (CML), a form of blood cancer that still presents treatment challenges despite decades of advances
The timing of the partnership is crucial, as Kerala’s fertility rate has dropped to approximately 1.35–1.7 children per woman, below the replacement level of 2.1
Subscribe To Our Newsletter & Stay Updated
